CLX Investment Company, Inc. (OTCBB: CLXN), a diversified investment fund with holdings in e-learning, global advertising and diagnostic testing markets, today announced that portfolio investment Zonda Incorporated, which specializes in diagnostic tests that serve the medical, bacterial food safety, cosmetic, beverage, pharmaceutical, veterinary, and environmental sanitation testing markets, has entered into a distribution agreement for its HandiLab-C test for chlamydia in Italy.
